Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorCabezón, Marta
dc.contributor.authorMalinverni, R.
dc.contributor.authorBargay, J.
dc.contributor.authorXicoy, Blanca
dc.contributor.authorMarcé, Silvia
dc.contributor.authorGarrido, A.
dc.contributor.authorValcarcel Ferreiras, David
dc.date.accessioned2021-05-27T07:54:57Z
dc.date.available2021-05-27T07:54:57Z
dc.date.issued2021-01-14
dc.identifier.citationCabezón M, Malinverni R, Bargay J, Xicoy B, Marcé S, Garrido A, et al. Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival. Clin Epigenetics. 2021 Jan 14;13:9.
dc.identifier.issn1868-7083
dc.identifier.urihttps://hdl.handle.net/11351/5979
dc.descriptionMetilació de l'ADN; Síndromes mielodisplàstiques; Factors pronòstics
dc.description.sponsorshipThis work was supported in part by a grant from Instituto de Salud Carlos III, Miniterio de Sanidad y Consumo, Spain (PI11/02519) and a grant from Celgene Spain. Research in the Buschbeck and Zamora labs is further supported by the following grants: the national grant RTI2018-094005-B-I00 from FEDER/Ministerio de Ciencia e Innovación – Agencia Estatal de Invsetigación (to MB); MINECO-ISCIII PIE16/00011 (to LZ and MB); the Deutsche José Carreras Leukämie Stiftung DJCLS 14R/2018 (to MB); AGAUR 2017-SGR-305 (to LZ and MB) and Fundació La Marató de TV3 254/C/2019 (to MB). Research at the IJC is supported by the “La Caixa” Foundation, the Fundació Internacional Josep Carreras, Celgene Spain and the CERCA Programme/Generalitat de Catalunya.
dc.language.isoeng
dc.publisherBMC
dc.relation.ispartofseriesClinical Epigenetics;13
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectLeucèmia mieloide aguda
dc.subjectPrognosi
dc.subjectMetilació
dc.subject.meshLeukemia, Myeloid, Acute
dc.subject.meshDNA Methylation
dc.subject.meshDiagnosis
dc.titleDifferent methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1186/s13148-021-01002-y
dc.subject.decsleucemia mielomonocítica aguda
dc.subject.decsmetilación del ADN
dc.subject.decsdiagnóstico
dc.relation.publishversionhttps://clinicalepigeneticsjournal.biomedcentral.com/articles/10.1186/s13148-021-01002-y
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Cabezón M, Xicoy B] Hematology Laboratory Service, ICO Badalona Hospital Germans Trias I Pujol, Myeloid Neoplasms Group, Josep Carreras Leukemia Research Institute (IJC), Badalona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Badalona, Spain. [Malinverni R] Cancer and Leukemia Epigenetics and Biology Program, Josep Carreras Leukemia Research Institute (IJC), Campus ICO GTP UAB, Badalona, Spain. [Bargay J] Hematology Service, Hospital Son Llàtzer, Palma de Mallorca, Spain. [Marcé S] Hematology Laboratory Service, ICO Badalona Hospital Germans Trias I Pujol, Myeloid Neoplasms Group, Josep Carreras Leukemia Research Institute (IJC), Badalona, Spain. [Garrido A] Hematology Service, Hospital de Sant Pau, Barcelona, Spain. [Valcárcel D] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid33446256
dc.identifier.wos000609189700001
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/1PN/2008-2011/PI11%2F02519
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2017-2020/RTI2018-094005-B-I00
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2013-2016/PIE16%2F00011
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PERIS2016-2020/2017SGR305
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple